THE TOCILIZUMAB IN THE DAYS OF COVID 19
Author: Antonia Mele AIFA a few days ago gave the go-ahead for the Tocilizumab trial to treat pneumonia induced by the new Coronavirus infection.Patients over 18 years of age with confirmed Covid 19 infection will be chosen for this study; however,
0